Scientists at Hiroshima University, Research Institute for Radiation Biology and Medicine publish research in myelodysplastic syndrome.(Report)

Data detailed in 'High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site' have been presented. "It is known that bone marrow is a sensitive organ to ionizing radiation, and many patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) have been diagnosed in radiation-treated cases and atomic bomb survivors in Hiroshima and Nagasaki. The AML1/RUNX1 gene has been known to be frequently mutated in MDS/AML patients among atomic bomb survivors and radiation therapy-related MDS/AML patients," scientists in Japan report (see also Myelodysplastic Syndrome).

"In this study, we …